Home About CDC Press Room Funding A-Z Index Centers, Institute & Offices Training & Employment Contact Us
CDC Centers for Disease Control and Prevention Home Page
_
_  
Search: 
 
_
Health & Safety TopicsPublications & ProductsData & StatisticsConferences & Events
_
Rocky Mountain Spotted Fever
Rocky Mountain Spotted Fever Home > Signs and Symptoms

Signs and Symptoms

Rocky Mountain spotted fever can be very difficult to diagnose in its early stages, even by experienced physicians who are familiar with the disease.

Patients infected with R. rickettsii generally visit a physician in the first week of their illness, following an incubation period of about 5-10 days after a tick bite. The early clinical presentation of Rocky Mountain spotted fever is nonspecific and may resemble a variety of other infectious and non-infectious diseases.

The classic triad of findings for this disease are fever, rash, and history of tick bite. However, this combination is not always detected when the patient initially presents for care.

Initial Signs and Symptoms

Picture- Early (macular) rash on sole of foot
Early (macular) rash on sole of foot

Initial symptoms may include fever, nausea, vomiting, severe headache, muscle pain, lack of appetite.

The rash first appears 2-5 days after the onset of fever and is often not present or may be very subtle when the patient is initially seen by a physician. Younger patients usually develop the rash earlier than older patients. Most often it begins as small, flat, pink, non-itchy spots (macules) on the wrists, forearms, and ankles. These spots turn pale when pressure is applied and eventually become raised on the skin.

 

Later Signs and Symptoms

Picture- Late (petechial) rash on palm of hand and forearm
Late (petechial) rash on palm and forearm

Later signs and symptoms include rash, abdominal pain, joint pain, diarrhea.

The characteristic red, spotted (petechial) rash of Rocky Mountain spotted fever is usually not seen until the sixth day or later after onset of symptoms, and this type of rash occurs in only 35% to 60% of patients with Rocky Mountain spotted fever. The rash involves the palms or soles in as many as 50% to 80% of patients; however, this distribution may not occur until later in the course of the disease. As many as 10% to 15% of patients may never develop a rash.

Abnormal Laboratory Findings

Abnormal laboratory findings seen in patients with Rocky Mountain spotted fever may include thrombocytopenia, hyponatremia, or elevated liver enzyme levels. See Laboratory Detection for more information on laboratory confirmation of Rocky Mountain spotted fever.

Hospitalization

Rocky Mountain spotted fever can be a very severe illness and patients often require hospitalization. Because R. rickettsii infects the cells lining blood vessels throughout the body, severe manifestations of this disease may involve the respiratory system, central nervous system, gastrointestinal system, or renal system. Host factors associated with severe or fatal Rocky Mountain spotted fever include advanced age, male sex, African-American race, chronic alcohol abuse, and glucose-6-phosphate dehydrogenase (G6PD) deficiency. Deficiency of G6PD is a sex-linked genetic condition which occurs with highest frequencies in people of African, Middle Eastern, and Southeast Asian origin; it affects approximately 12% of the U.S. African-American male population; deficiency of this enzyme is associated with a high proportion of severe cases of Rocky Mountain spotted fever. This is a rare clinical course that is often fatal within 5 days of onset of illness.

Long-term Health Problems

Long-term health problems following acute Rocky Mountain spotted fever infection include partial paralysis of the lower extremities, gangrene requiring amputation of fingers, toes, or arms or legs, hearing loss, loss of bowel or bladder control, movement disorders, and language disorders. These complications are most frequent in persons recovering from severe, life-threatening disease, often following lengthy hospitalizations.

Date last reviewed: 05/20/2005

_
blue divider
Program Contents
bullet Home
bullet Overview
bullet Questions and Answers
bullet The Organism
bullet Natural History
bullet Epidemiology
bullet Signs and Symptoms
bullet Laboratory Detection
bullet Treatment
bullet Prevention and Control
bullet References and Resources
bullet Glossary
bullet Case Report Form Adobe Acrobat Reader
(1.2 MB, 3 pages)
Tick-Borne Rickettsial Disease Case Report. Use for reporting cases of RMS, HME, and HGE.
blue divider
Contact Info

1600 Clifton Road, MS-G13
Atlanta, GA 30033
Phone: +1(404) 639-3534
+1(800) 311-3435

grey divider
 
 
    Home   |   Policies and Regulations   |   Disclaimer   |   e-Government   |  FOIA   |  Contact Us  
Safer, Healthier People USAGovDHHS Department of Health
and Human Services
Centers for Disease Control and Prevention,1600 Clifton Rd, Atlanta, GA 30333, U.S.A
Tel: (404) 639-3311 / Public Inquiries: (404) 639-3534 / (800) 311-3435